Triptolide: structural modifications, structure–activity relationships, bioactivities, clinical development and mechanisms

2012 ◽  
Vol 29 (4) ◽  
pp. 457 ◽  
Author(s):  
Zhao-Li Zhou ◽  
Ya-Xi Yang ◽  
Jian Ding ◽  
Yuan-Chao Li ◽  
Ze-Hong Miao
2019 ◽  
Vol 33 (3) ◽  
pp. 406-414 ◽  
Author(s):  
Adam L Halberstadt ◽  
Muhammad Chatha ◽  
Stephen J Chapman ◽  
Simon D Brandt

Background: In recent years, there has been increasing scientific interest in the effects and pharmacology of serotonergic hallucinogens. While a large amount of experimental work has been conducted to characterize the behavioral response to hallucinogens in rodents, there has been little systematic investigation of mescaline and its analogs. The hallucinogenic potency of mescaline is increased by α-methylation and by homologation of the 4-methoxy group but it not clear whether these structural modifications have similar effects on the activity of mescaline in rodent models. Methods: In the present study, the head twitch response (HTR), a 5-HT2A receptor-mediated behavior induced by serotonergic hallucinogens, was used to assess the effects of mescaline and several analogs in C57BL/6J mice. HTR experiments were conducted with mescaline, escaline (4-ethoxy-3,5-dimethoxyphenylethylamine) and proscaline (3,5-dimethoxy-4-propoxyphenylethylamine), their α-methyl homologs TMA (3,4,5-trimethoxyamphetamine), 3C-E (4-ethoxy-3,5-dimethoxyamphetamine) and 3C-P (3,5-dimethoxy-4-propoxyamphetamine), and the 2,4,5-substituted regioisomers TMA-2 (2,4,5-trimethoxyamphetamine), MEM (4-ethoxy-2,5-dimethoxyamphetamine) and MPM (2,5-dimethoxy-4-propoxyamphetamine). Results: TMA induced the HTR and was twice as potent as mescaline. For both mescaline and TMA, replacing the 4-methoxy substituent with an ethoxy or propoxy group increased potency in the HTR assay. By contrast, although TMA-2 also induced the HTR with twice the potency of mescaline, potency was not altered by homologation of the 4-alkoxy group in TMA-2. Conclusions: The potency relationships for these compounds in mice closely parallel the human hallucinogenic data. These findings are consistent with evidence that 2,4,5- and 3,4,5-substituted phenylalkylamine hallucinogens exhibit distinct structure-activity relationships. These results provide additional evidence that the HTR assay can be used to investigate the structure-activity relationships of serotonergic hallucinogens.


2006 ◽  
Vol 16 (16) ◽  
pp. 4339-4344 ◽  
Author(s):  
Kim F. McClure ◽  
Michael A. Letavic ◽  
Amit S. Kalgutkar ◽  
Christopher A. Gabel ◽  
Laurent Audoly ◽  
...  

2020 ◽  
Vol 20 (5) ◽  
pp. 369-395 ◽  
Author(s):  
Xiaobo Huang ◽  
Hui Xu

Cytisine is a quinolizidine alkaloid isolated from various Leguminosae plants. Cytisine and its derivatives exhibit a broad range of biological properties, such as smoking cessation aid, antidepressant, neuroprotective, nootropic, anticancer, antiviral, antiparasitic, antidiabetic, insecticidal, and nematicidal activities. In this review, the progress of cytisine and its derivatives in regard to bioactivities, total synthesis, structural modifications focusing on their N-12 position and lactam ring is reported. Additionally, the structure-activity relationships of cytisine and its derivatives are also discussed.


Molecules ◽  
2020 ◽  
Vol 25 (20) ◽  
pp. 4629
Author(s):  
Ngoc Uy Nguyen ◽  
Brendan David Stamper

Background: Structure-activity relationships describe the relationship between chemical structure and biologic activity and are capable of informing deliberate structural modifications to a molecule in order enhance drug properties. Methods: Here, we present a subtle, yet unique twist on structure-activity relationships in which a collective biologic activity was measured among five cinnamon constituents with a shared phenylpropanoid template (cinnamic acid, cinnamaldehyde, chlorogenic acid, caffeic acid, and ferulic acid). This template-based approach utilized publicly available transcriptomic data through the Gene Expression Omnibus (GEO) to identify a fundamental biologic effect; in essence, a phenylpropanoid template effect. Results: The recurrent identification of cytokine-cytokine receptor interaction and neuroactive ligand receptor pathways in each individual treatment condition strongly supports the fact that changes in gene expression within these pathways is a hallmark of the phenylpropanoid template. With a template effect identified, future structural modifications can be performed in order to overcome pharmacokinetic barriers to clinical use (i.e., traditional structure-activity relationship experiments). Moreover, these modifications can be implemented with a high degree of confidence knowing that a consistent and robust template effect is likely to persist. Conclusion: We believe this template-based approach offers researchers an attractive and cost-effective means for evaluating multicomponent natural products during drug development.


2018 ◽  
Vol 47 (3) ◽  
pp. 909-928 ◽  
Author(s):  
Samuel M. Meier-Menches ◽  
Christopher Gerner ◽  
Walter Berger ◽  
Christian G. Hartinger ◽  
Bernhard K. Keppler

The drug discovery process of ruthenium and osmium anticancer therapeutics is described, including global structure–activity relationships.


Sign in / Sign up

Export Citation Format

Share Document